BitRss.com latest Crypto World News

Search and discover the latest Cryptocurrency updated Stories in Categories.

24-7 Cryptocurrency News about Blockchain, Technology and much more, only from Top Leading Sources.

Linum Labs Announces Decentralised Healthcare R&D Funding Platform ‘Molecule’

Linum Labs Announces Decentralised Healthcare R&D Funding Platform ‘Molecule’
Blockchain development company Linum Labs has announced the launch of a decentralised open-source funding platform to fast-track innovation in pharma called Molecule.
The Molecule Platform
Linum Labs , which deals with blockchain-based solutions in healthcare and identity, has created the Molecule platform in order to bring together industry, patients, and scientists in an open collaborative market where drug development can be advanced.
The open platform allows participants to contribute funds towards drug development, thereby, achieving Lunum Labs’ goal of distributing cost and risk.
To achieve this, Linum Labs is leveraging blockchain technology and open science to build a fair and accountable market-based platform for the research and funding of pharmaceutical intellectual property.
The Decentralised Answer to the Pharma Research Monolopy
Molecule aims to solve the problem of the monopolisation of research in the pharmaceutical industry, reduced trust, and the expensive, risky, and slow nature of drug development.
Paul Kohlhaas, CEO of Linum Labs, stated: “The pharmaceutical industry faces an innovation crisis caused by the challenges around drug development and the monopolisation of IP. Bringing a drug to market is a high-cost, high-risk, and slow endeavour, and it is generally large organisations that single-handedly shoulder these burdens, leading to massively inflated prices and a lack of innovation.”
Molecule solves these challenges by offering a low-friction crowdsourcing research and funding platform that reduces risk to investors and IP creators in an inclusive environment.
“Molecule enables new economic incentive models for distributed R&D that leverage open science, Web3 and bonding curves to create a fair and accountable market-based platform for the discovery and funding of pharmaceutical IP. The ecosystem aims to align all stakeholders to collaborate in order to move away from environments where only ‘blockbuster drugs’ get approved for development, and towards a more patient-focused approach,” Kohlhaas added.
Development

Linum Labs AG started building Molecule in early 2018 on behalf of Swiss non-profit, the Molecule Foundation.
The next stage of “development will include further iterations of the initial proof-of-concept, leading into a minimum viable product,” Linum Labs writes in a statement. This stage will be backed by a financial round that will begin in the second quarter of 2019.
Linum Labs is presently hiring and looking for partners to back the Molecule platform.
The post Linum Labs Announces Decentralised Healthcare R&D Funding Platform ‘Molecule’ appeared first on BitcoinAfrica.io .

- - - - -

Thank you for Share!

   
Read the full Article

Read the full Article: Linum Labs Announces Decentralised Healthcare R&D Funding Platform ‘Molecule’


Search Crypto News


BITRSS | CRYPTOCURRENCY WORLD NEWS

The latest Top News, from leading exponents of BlockChain, Bitcoin and Accredited Crypto Currency Sources.

Since 2015, our Mission was to Share, up-to-date, those News and Information we believe to represent in an Ethical and sincere manner the current Cypto Currencies World.

We have always tried to give priority to the News; for this reason we have designed BitRss.com simple and intuitive, usable by all Devices, fast and effective.


| LEARN MORE ABOUT |

24h Most Popular News